SNN logo

Smith & Nephew (SNN)

Profile

Full Name

Smith & Nephew plc

Ticker Symbol

SNN

Exchange

NYSE

Sector

Healthcare

Industry

Medical Devices

Country

United Kingdom

IPO

November 16, 1999

Indexes

Not included

Website

http://www.smith-nephew.com

Employees

17349

Key Details

Price

$26.03(-0.08%)

Market cap

Last Dividend

$0.46

TTM Dividend yield

2.88%

Annual revenue

$5.81B(+4.70% YoY)

Annual EPS

$0.94(+56.15% YoY)

PE ratio

-

Next earnings date

Jul 31, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$26.03
SNN price is $26.03

30-Day Relative Volume

1.26
SNN 30-day relative volume is 1.26

Price Performance

Price Most recent change

-0.08%
SNN price was down -0.08% on Apr 15, 2025

Price YTD change

+5.9%
SNN price is up +5.9% since January 1st

Price 1-year change

+9.37%
SNN price is up +9.37% year-on-year

Price 3-year change

-16.38%
SNN price is down -16.38% over the past 3 years

Price Range

Price All-time high

$52.26
SNN price is currently -50.19% below its historical high of $52.26

Price 3-year low

$21.53
SNN price is currently +20.90% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$11.37B
SNN market capitalization is $11.37 billion

Market cap 3-year change

-16.11%
SNN market capitalization is down -16.11% over the past 3 years

Market cap All-time high

$22.60B
SNN market capitalization is currently -49.69% below its historical high of $22.60 billion

Market cap sector rank

93.34%
SNN market capitalization is higher than 93.34% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.18%
SNN shares outstanding is up +0.18% year-on-year

Shares Outstanding 3-Year Change

+0.33%
SNN shares outstanding is up +0.33% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.47
SNN beta is 0.47

200-day SMA

$27.57
SNN price is currently -5.58% below its 200-day simple moving average

50-day SMA

$27.40
SNN price is currently -5.01% below its 50-day simple moving average

RSI

41.07
SNN 14-day relative strength index is 41.07

Volume

1.26
SNN 30-day relative volume is 1.26

ATR

$0.74
SNN average true range is $0.74

10-day Historical Volatility

45.77%
SNN 10-day historical volatility is 45.77%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.46
SNN last dividend was $0.46 per share, with an ex-dividend date of March 28, 2025

Next Dividend

-
SNN next dividend has not yet been announced

Dividend per share

Dividend per share

$0.75
SNN annual dividend per share is $0.75

Dividend per share Sector Rank

30.23%
SNN annual dividend per share is higher than 30.23% of companies in Healthcare sector

Dividend per share 1-Year Change

0%
SNN {parameterFullLabel} has remained unchanged year-on-year

Dividend per share 3-Year Change

0%
SNN {parameterFullLabel} has remained unchanged over the past 3 years

Dividend yield

Dividend yield

2.88%
SNN annual dividend yield is 2.88%

Dividend yield Sector Rank

60%
SNN annual dividend yield is higher than 60% of companies in Healthcare sector

Other

Payout ratio

79.37%
SNN annual payout ratio is 79.37%

Dividends paid

$327.00M
SNN annual dividends paid is $327.00 million

Free cash flow

$606.00M
SNN annual free cash flow is $606.00 million

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$5.81B
SNN annual revenue is $5.81 billion

Revenue Analysts estimate

$6.07B
SNN annual revenue is currently -4.22% lower than the consensus analysts' forecast

Revenue 1-year change

+4.7%
SNN annual revenue is up +4.7% year-on-year

Revenue Sector rank

92.4%
SNN annual revenue is higher than 92.4% of companies in Healthcare sector

EPS

EPS

$0.94
SNN annual earnings per share is $0.94

EPS Analysts estimate

$1.71
SNN annual earnings per share is currently -45.14% lower than the consensus analysts' forecast

EPS 1-year change

+56.15%
SNN annual earnings per share is up +56.15% year-on-year

EPS Sector rank

89.06%
SNN annual earnings per share is higher than 89.06% of companies in Healthcare sector

Profit

Gross profit

$4.05B
SNN annual gross profit is $4.05 billion

Gross margin

69.64%
SNN annual gross profit margin is 69.64%

Operating profit

$657.00M
SNN annual operating income is $657.00 million

Operating margin

11.31%
SNN annual operating profit margin is 11.31%

Net income

$412.00M
SNN annual net profit is $412.00 million

Net margin

7.09%
SNN annual net profit margin is 7.09%

Expenses

Total expenses

$5.15B
SNN annual total expenses is $5.15 billion

Operating expenses

$3.39B
SNN annual total operating expenses is $3.39 billion

Cost of goods sold

$1.76B
SNN annual cost of goods sold is $1.76 billion

Selling, general & administrative expenses

$2.65B
SNN annual SGA is $2.65 billion

Depreciation and amortization

$555.00M
SNN annual depreciation & amortization is $555.00 million

Interest expense

$168.00M
SNN annual interest expense is $168.00 million

Income tax

$86.00M
SNN annual income tax is $86.00 million

EBIT & EBITDA

EBIT

$643.00M
SNN annual earnings before interest & taxes is $643.00 million

EBITDA

$1.29B
SNN annual EBITDA is $1.29 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$10.35B
SNN annual total assets is $10.35 billion

Non current assets

$5.93B
SNN annual long term assets is $5.93 billion

Current assets

$4.42B
SNN annual total current assets is $4.42 billion

Cash and cash equivalents

$619.00M
SNN annual cash & cash equivalents is $619.00 million

Accounts receivable

$1.06B
SNN annual accounts receivable is $1.06 billion

Inventory

$2.39B
SNN annual inventory is $2.39 billion

Liabilities

Total liabilities

$5.09B
SNN annual total liabilities is $5.09 billion

Long term liabilities

$3.56B
SNN annual total long term liabilities is $3.56 billion

Current liabilities

$1.53B
SNN annual total current liabilities is $1.53 billion

Accounts payable

$1.08B
SNN annual accounts payable is $1.08 billion

Debt

Total debt

$3.32B
SNN annual total debt is $3.32 billion

Total debt 1-year change

+7.68%
SNN annual total debt is up +7.68% year-on-year

Long term debt

$3.26B
SNN annual long term debt is $3.26 billion

Short term debt

$63.00M
SNN annual short term debt is $63.00 million

Equity & Capital

Shareholders equity

$5.26B
SNN annual stockholders equity is $5.26 billion

Book value

$5.26B
SNN annual book value is $5.26 billion

Retained earnings

$5.02B
SNN annual retained earnings is $5.02 billion

Working capital

$2.89B
SNN annual working capital is $2.89 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$987.00M
SNN annual cash flow from operations is $987.00 million

Cash from operations 1-year change

+62.34%
SNN annual cash flow from operations is up +62.34% year-on-year

Cash from investing

-$569.00M
SNN annual cash flow from investing activities is -$569.00 million

Cash from investing 1-year change

-27.01%
SNN annual cash flow from investing activities is down -27.01% year-on-year

Cash from financing

-$86.00M
SNN annual cash flow from financing activities is -$86.00 million

Cash from financing 1-year change

+57%
SNN annual cash flow from financing activities is up +57% year-on-year

CAPEX

CAPEX

$381.00M
SNN annual capital expenditures is $381.00 million

CAPEX 1-year change

-10.77%
SNN annual capital expenditures is down -10.77% year-on-year

Free Cash Flow

Free cash flow

$606.00M
SNN annual free cash flow is $606.00 million

Free cash flow 1-year change

+234.81%
SNN annual free cash flow is up +234.81% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

69.64%
SNN annual gross profit margin is 69.64%

Operating margin

11.31%
SNN annual operating profit margin is 11.31%

Net margin

7.09%
SNN annual net profit margin is 7.09%

ROA & ROE

ROA

4.05%
SNN annual return on assets is 4.05%

ROE

7.86%
SNN annual return on equity is 7.86%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
SNN price to earnings ratio value is unknown

PE ratio Sector rank

-
SNN price to earnings ratio is unknown

PB Ratio

PB ratio

2.16
SNN price to book ratio is 2.16

PB ratio Sector rank

64.94%
SNN price to book ratio is higher than 64.94% of companies in Healthcare sector

PS Ratio

PS ratio

-
SNN price to sales ratio value is unknown

PS ratio Sector rank

-
SNN price to sales ratio is unknown

Enterprise value

Enterprise value

$14.07B
SNN enterprise value is $14.07 billion

Enterprise value Sector rank

93.8%
SNN enterprise value is higher than 93.8% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
SNN EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
SNN EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

2.89
SNN annual current ratio is 2.89

Quick ratio

1.33
SNN annual quick ratio is 1.33

Leverage

Debt to equity

0.59
SNN annual debt to equity ratio is 0.59

Interest coverage ratio

3.83
SNN annual interest coverage ratio is 3.83

Risk & Stability

Piotroski F-Score

-
SNN piotroski f-score value is unknown

Altman Z-Score

3.12
SNN altman z-score is 3.12

Analyst ratings

Recent major analysts updates

Mar 17, 25 Canaccord Genuity
Hold
Mar 12, 25 UBS
Neutral
Feb 26, 25 Canaccord Genuity
Hold
Jun 5, 24 UBS
Buy
Oct 4, 23 Bernstein
Outperform
Mar 4, 22 Redburn Partners
Neutral
Apr 30, 21 Canaccord Genuity
Buy
Dec 18, 20 Bernstein
Outperform
Oct 30, 20 Canaccord Genuity
Buy
May 7, 20 CFRA
Hold

Institutional Ownership

Similar stocks

SOLV logo
Solventum (SOLV)
UHS logo
Universal Health Services (UHS)
INCY logo
Incyte (INCY)
BMRN logo
BioMarin Pharmaceutical (BMRN)
RVTY logo
Revvity (RVTY)
THC logo
Tenet Healthcare (THC)
RDY logo
Dr Reddys Laboratories Limited (RDY)
DVA logo
DaVita (DVA)
ICLR logo
ICON Public Limited (ICLR)
  • What is the ticker symbol for Smith & Nephew?
  • Does Smith & Nephew pay dividends?
  • What sector is Smith & Nephew in?
  • What industry is Smith & Nephew in?
  • What country is Smith & Nephew based in?
  • When did Smith & Nephew go public?
  • Is Smith & Nephew in the S&P 500?
  • Is Smith & Nephew in the NASDAQ 100?
  • Is Smith & Nephew in the Dow Jones?
  • When was Smith & Nephew's last earnings report?
  • When does Smith & Nephew report earnings?
  • Should I buy Smith & Nephew stock now?

What is the ticker symbol for Smith & Nephew?

The ticker symbol for Smith & Nephew is NYSE:SNN

Does Smith & Nephew pay dividends?

Yes, Smith & Nephew pays dividends. The last payment was $0.46, with an ex-dividend date on March 28, 2025

What sector is Smith & Nephew in?

Smith & Nephew is in the Healthcare sector

What industry is Smith & Nephew in?

Smith & Nephew is in the Medical Devices industry

What country is Smith & Nephew based in?

Smith & Nephew is headquartered in United Kingdom

When did Smith & Nephew go public?

Smith & Nephew's initial public offering (IPO) was on November 16, 1999

Is Smith & Nephew in the S&P 500?

No, Smith & Nephew is not included in the S&P 500 index

Is Smith & Nephew in the NASDAQ 100?

No, Smith & Nephew is not included in the NASDAQ 100 index

Is Smith & Nephew in the Dow Jones?

No, Smith & Nephew is not included in the Dow Jones index

When was Smith & Nephew's last earnings report?

Smith & Nephew's most recent earnings report was on Feb 25, 2025

When does Smith & Nephew report earnings?

The next expected earnings date for Smith & Nephew is Jul 31, 2025

Should I buy Smith & Nephew stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page